ArticleInternational journal of surgery (London, England)2026
Global epidemiology and mortality trends of necrotizing fasciitis: a systematic review and meta-analysis with a focus on monomicrobial Gram-negative infections.
Article in International journal of surgery (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Lactobacillus johnsonii DM2420 Alleviates Dyslipidemia, Remodels Gut Microbiota, and Modulates the Intestinal CD36/SREBP1 Signaling Axis.Probiotics and antimicrobial proteins · 2026Article
- Hyperbaric oxygen therapy for necrotizing fasciitis: a narrative review of mechanisms, clinical evidence, controversies, and practical considerations.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNecrotizing fasciitis (NF) is a fulminant soft-tissue infection with high in-hospital mortality. Although NF is traditionally classified into types I-IV by microbiology, emerging data - particularly from East Asia - suggest that monomicrobial Gram-negative (mono-GNB) NF is epidemiologically and prognostically distinct. This systematic review and meta-analysis aimed to quantify global subtype distributions and in-hospital mortality, with a focus on mono-GNB NF.
methodsWe searched PubMed/MEDLINE, Embase, Web of Science, and Cochrane Library from inception to 1 September 2023, for eligible studies reporting NF microbiology. Included cases were classified as polymicrobial, monomicrobial Gram-positive, mono-GNB, culture-negative, or other pathogen-related. The primary outcomes were the pooled proportion of mono-GNB NF cases and the associated in-hospital mortality. We used random-effects models to estimate pooled proportions and mortality rates, and we conducted subgroup analyses by time period (before 2000 vs. from 2000 onward) and the six World Health Organization (WHO) regions.
resultsA total of 142 studies encompassing 6740 patients were included. Globally, the pooled proportion of mono-GNB NF increased from 12% before 2000 to 18% from 2000 onward (P = 0.03). Between-study heterogeneity was substantial (I2 > 95%). The proportion of mono-GNB cases was highest in the WHO regions of the Western Pacific, South-East Asia, and Africa. Among NF subtypes, mono-GNB NF exhibited the highest in-hospital mortality (28% before 2000 vs. 22% from 2000 onward; P = 0.70). Between-study heterogeneity was moderate (I2 = 41%).
conclusionThe rising proportion and persistently high in-hospital mortality of mono-GNB NF support its recognition as a distinct NF subtype and warrant reconsideration of the conventional NF classifications. In high-prevalence regions, empiric antimicrobial regimens should include prompt Gram-negative coverage to complement surgical debridement, while sustained epidemiological surveillance remains essential.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.